These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Insertion and removal of Norplant]. Townsend S Netw Fr; 1991 May; 6(1):8-9. PubMed ID: 12319670 [TBL] [Abstract][Full Text] [Related]
43. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017 [TBL] [Abstract][Full Text] [Related]
44. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant). Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775 [TBL] [Abstract][Full Text] [Related]
45. Another view on Norplant: match method with users. Herndon N Netw Res Triangle Park N C; 1992 Oct; 13(2):24-6. PubMed ID: 12286081 [TBL] [Abstract][Full Text] [Related]
46. Keloid formation from levonorgestrel implant (Norplant System) insertion. Nuovo J; Sweha A J Am Board Fam Pract; 1994; 7(2):152-4. PubMed ID: 7857393 [TBL] [Abstract][Full Text] [Related]
47. [Norplant contraceptive implants: opinion of Dominican women who used this method]. Hardy E; Baez C; Faundes A; Alvarez F; Brache V Acta Med Dom; 1990; 12(1):1-6. PubMed ID: 12292702 [TBL] [Abstract][Full Text] [Related]
55. The attitudes of clinic staff as factors in women's selection of Norplant implants for their contraception. Frank ML; Bateman L; Poindexter AN Women Health; 1994; 21(4):75-88. PubMed ID: 7941612 [TBL] [Abstract][Full Text] [Related]
56. Real-time ultrasonographically guided removal of nonpalpable and intramuscular Norplant capsules. Nelson AL; Sinow RM Am J Obstet Gynecol; 1998 Jun; 178(6):1185-93. PubMed ID: 9662300 [TBL] [Abstract][Full Text] [Related]
57. Three countries' experience with Norplant introduction. Hardee K; Balogh S; Villinski MT Health Policy Plan; 1997 Sep; 12(3):199-213. PubMed ID: 10173401 [TBL] [Abstract][Full Text] [Related]
58. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant. Piper JG; Follett KA; Fantin A Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172 [TBL] [Abstract][Full Text] [Related]
59. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Goodger AM; Rogers PA; Affandi B Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724 [TBL] [Abstract][Full Text] [Related]
60. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]